Reassessment of tigecycline bone concentrations in volunteers undergoing elective orthopedic procedures

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Journal of clinical pharmacology

• Publication date

  2014-01-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/jcph.201PMID 24155157
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Therapeutic options for diabetic foot infections: a review with an emphasis on tissue penetration characteristics.

  2010cited by this paper
• Phase 3 study comparing tigecycline (tgc) and ertapenem (ert) in patients (pts) with diabetic foot infections (dfi) with and without osteomyelitis

  2009cited by this paper
• A sensitive human bone assay for quantitation of tigecycline using LC/MS/MS.

  2008cited by this paper
• Tigecycline pharmacokinetic/pharmacodynamic update.

  2008cited by this paper
• A novel antibiotic bone assay by liquid chromatography/tandem mass spectrometry for quantitation of tigecycline in rat bone.

  2007cited by this paper
• Serum, tissue and body fluid concentrations of tigecycline after a single 100 mg dose.

  2006influential reference
• Pharmacokinetics of Tigecycline after Single and Multiple Doses in Healthy Subjects

  2005cited by this paper
• Comparative evaluation of tigecycline and vancomycin, with and without rifampicin, in the treatment of methicillin-resistant Staphylococcus aureus experimental osteomyelitis in a rabbit model.

  2005cited by this paper
• Effects of Age and Sex on Single-Dose Pharmacokinetics of Tigecycline in Healthy Subjects

  2005cited by this paper
• New developments in tetracycline antibiotics: glycylcyclines and tetracycline efflux pump inhibitors.

  2002cited by this paper
• Synthesis and structure-activity relationship of novel glycylcycline derivatives leading to the discovery of GAR-936.

  1999cited by this paper
• Review Board

  1984cited by this paper

• Infectious spondylodiscitis: When a rare infection is associated with uncommon findings!

  2024cites this paper
• Infectious spondylodiscitis: When a rare infection is associated with uncommon findings!

  2022cites this paper
• Dose optimization based on pharmacokinetic/pharmacodynamic target of tigecycline.

  2021cites this paper
• Tigecycline antibacterial activity, clinical effectiveness, and mechanisms and epidemiology of resistance: narrative review

  2021cites this paper
• Tibial Osteomyelitis Caused by Carbapenem-Resistant Enterobacter cloacae

  2020cites this paper
• Minocycline Combined with Vancomycin for the Treatment of Methicillin-Resistant Coagulase-Negative Staphylococcal Prosthetic Joint Infection Managed with Exchange Arthroplasty

  2020cites this paper
• [Off label uses of tigecycline].

  2020cites this paper
• Hip and Knee Section, Treatment, Antimicrobials: Proceedings of International Consensus on Orthopedic Infections.

  2019cites this paper
• Optimizing the treatment of osteomyelitis with antimicrobial drugs: current concepts

  2017cites this paper
• Determination of tigecycline in turkey plasma by LC-MS/MS: validation and application in a pharmacokinetic study.

  2017influential citation
• Brown Adipose Tissue Regulates Small Artery Function Through NADPH Oxidase 4–Derived Hydrogen Peroxide and Redox-Sensitive Protein Kinase G-1&agr;

  2017cites this paper
• First report of Klebsiella pneumoniae carbapenemase-producing K. pneumoniae sternum osteomyelitis relapsing 6 years after mediastinitis following cardiac surgery.

  2017cites this paper
• Prolonged and high dosage of tigecycline – successful treatment of spondylodiscitis caused by multidrug-resistant Acinetobacter baumannii: a case report

  2017cites this paper
• Diabetic foot syndrome: importance of microbiological monitoring and antimicrobial penetration of chemotherapeutic agents into the soft tissue lower limb in determining the treatment

  2016cites this paper
• Re-defining tigecycline therapy.

  2015influential citation
• Successful use of tigecycline for treatment of culture-negative pyogenic vertebral osteomyelitis

  2015cites this paper